Results 281 to 290 of about 17,612,218 (346)

HLA-DRB1*01 predicts treatment outcome in juvenile idiopathic arthritis: A retrospective-prospective cohort study. [PDF]

open access: yesBiomol Biomed
Čengić A   +8 more
europepmc   +1 more source

The influence of ROS1 fusion partners and resistance mechanisms in ROS1‐TKI‐treated non‐small cell lung cancer patients

open access: yesMolecular Oncology, EarlyView.
This real‐world study of ROS1+ NSCLC highlights fusion diversity, treatment outcomes with crizotinib and lorlatinib, and in vitro experiments with resistance mechanisms. G2032R drives strong resistance to ROS1‐targeted TKIs, especially lorlatinib. Fusion partner location does not affect overall survival to crizotinib or lorlatinib. Findings support the
Fenneke Zwierenga   +8 more
wiley   +1 more source

Analysis of the treatment outcome of duodenal varices: A retrospective case series of 15 patients from a single institution. [PDF]

open access: yesDEN Open
Mitamura Y   +23 more
europepmc   +1 more source

YAP1::TFE3 mediates endothelial‐to‐mesenchymal plasticity in epithelioid hemangioendothelioma

open access: yesMolecular Oncology, EarlyView.
The YAP1::TFE3 fusion protein drives endothelial‐to‐mesenchymal transition (EndMT) plasticity, resulting in the loss of endothelial characteristics and gain of mesenchymal‐like properties, including resistance to anoikis, increased migratory capacity, and loss of contact growth inhibition in endothelial cells.
Ant Murphy   +9 more
wiley   +1 more source

The effect of GM-CSF and predictors of treatment outcome in pediatric septic shock patients. [PDF]

open access: yesItal J Pediatr
Yu ZH   +9 more
europepmc   +1 more source

HMGA2 Expression Predicts Subtype, Survival, and Treatment Outcome in Pancreatic Ductal Adenocarcinoma. [PDF]

open access: yesClin Cancer Res
Yamamoto N   +21 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy